The role of cost-effectiveness in U.S. vaccination policy

N Engl J Med. 2011 Nov 10;365(19):1760-1. doi: 10.1056/NEJMp1110539. Epub 2011 Oct 19.

Author

Jane J Kim¹

Affiliation

¹ Center for Health Decision Science, Department of Health Policy and Management, Harvard School of Public Health, Boston, USA

PMID: 22010866
DOI: 10.1056/NEJMp1110539

No abstract available

MeSH terms

Adolescent
Advisory Committees
Child
Cost-Benefit Analysis
Female
Health Policy / economics*
Humans
Infant
Male
Meningococcal Vaccines / economics*
Papillomavirus Vaccines / economics*
United States
Vaccination / economics*
Young Adult

Substances

Meningococcal Vaccines
Papillomavirus Vaccines